HomeAPGE • NASDAQ
add
Apogee Therapeutics Inc
Previous close
$74.55
Day range
$73.51 - $75.00
Year range
$26.20 - $75.00
Market cap
5.08B USD
Avg Volume
714.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 71.28M | 21.46% |
Net income | -65.02M | -32.65% |
Net profit margin | — | — |
Earnings per share | -1.11 | -29.07% |
EBITDA | -70.87M | -20.86% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 527.29M | 0.24% |
Total assets | 626.16M | -19.34% |
Total liabilities | 39.82M | -4.93% |
Total equity | 586.34M | — |
Shares outstanding | 67.49M | — |
Price to book | 7.54 | — |
Return on assets | -27.76% | — |
Return on capital | -29.06% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -65.02M | -32.65% |
Cash from operations | -54.26M | -27.59% |
Cash from investing | 17.94M | 112.26% |
Cash from financing | 19.74M | 5,053.52% |
Net change in cash | -16.57M | 91.21% |
Free cash flow | -31.93M | -15.93% |
About
Founded
2022
Headquarters
Website
Employees
196
